Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow
about
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.Turning the tide in myelodysplastic/myeloproliferative neoplasms.Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
P2860
Q30274942-D6E2CD72-C721-4CB5-BC7D-9344A2F35240Q38603384-FF6D1B15-D5A8-4696-9CF1-B25580C08B5BQ38644826-0C478FBA-8305-44FC-A957-AD6C0407B02BQ38712988-E3E854D0-9C24-4924-B4CE-59B0CDDC0530Q38722106-C2725D30-90B1-462C-9ACD-989B85E5F4B3Q38835771-D733F24E-593D-4AB7-A1F4-3C4119EFBD8DQ38859646-2E162579-49DD-4320-B0FF-151B12392179Q39092515-AF6BD5AF-5411-4C13-A813-AF0A610E034DQ47793309-D33E1D90-A8EE-4BCB-93D9-E3DE0A749B92Q48137636-4EFD3F5B-9D91-4D21-AFBD-C6C23997EF19Q52661221-620DBAE4-1E34-4D41-A600-B06F04FBF301Q52846378-AEA876A4-8E28-4BA6-A476-9FA56727A8D0
P2860
Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Achievement of complete remiss ...... ean Group for Blood and Marrow
@ast
Achievement of complete remiss ...... ean Group for Blood and Marrow
@en
type
label
Achievement of complete remiss ...... ean Group for Blood and Marrow
@ast
Achievement of complete remiss ...... ean Group for Blood and Marrow
@en
prefLabel
Achievement of complete remiss ...... ean Group for Blood and Marrow
@ast
Achievement of complete remiss ...... ean Group for Blood and Marrow
@en
P2093
P2860
P50
P356
P1476
Achievement of complete remiss ...... ood and Marrow Transplantation
@en
P2093
Alfonso Piciocchi
Anja van Biezen
Arnold Ganser
Benedetto Bruno
Chronic Malignancies Working P ...... ood and Marrow Transplantation
Dietger Niederwieser
Dietrich Beelen
Ghulam Mufti
Guido Kobbe
Jan Cornelissen
P2860
P304
P356
10.1111/BJH.13576
P407
P577
2015-07-26T00:00:00Z